Covid19
Conditions
Keywords
Ivermectin intranasal spray in covid19
Brief summary
Ivermectin showed a strong viricidal effect upon covid19 virus in vitro as proved by many authors according to many studies , covid virus stay in postnasal space for 4 days before starting general manifestation, so ivermectin mucoadhesive nanosuspension sprayed inside the nose and post nasal space may help in early management of covid19 and may play a great rule in prophylaxis as well
Detailed description
150 patient with early covid is devided into two groups first group will receive regular protocol of drugs second group will receive ivermectin nasal spray in addition to regular protocl of drugs
Interventions
DRUGintranasal ivermectin spray
usage of ivermectin as intranasal spray for treating early covid patiens
Sponsors
South Valley University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* early covid19 pateints
Exclusion criteria
* children and pregnant women
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| progression of covid 19 clinical picture | [ Time Frame: within 14 days after enrollement ] | progress of Symptoms ( Fever ,Cough, Sore Throat, Myalgia,Diarrhea, Shortness of Breath)with radiological assesment and blood tests |
Countries
Egypt
Outcome results
None listed